UgenTec NV
Latest round
- Series A
Last raised
- Apr 2018
Total raised
- $6.1M
Investors
- 4
About UgenTec NV
Founded in 2014 in Hasselt, Belgium, UgenTec NV specializes in developing advanced software for molecular diagnostics. The company was founded by Tom Martens and Wouter Uten.U.istart.UgenTec, now operating as Velsera, specializes in providing a comprehensive suite of laboratory software solutions tailored for molecular diagnostics. Their flagship offerings include the FastFinder platform, which encompasses various tools such as FastFinder Workflow, FastFinder Analysis, FastFinder Insights, FastFinder QC, and FastFinder Genotyper. These products streamline laboratory operations by automating sample workflows, result calling, quality control, and data analysis, delivering reliable and reproducible results crucial for clinical decision-making. The FastFinder platform is designed for clinical laboratories, assay providers, and research institutions, enhancing efficiency and accuracy in testing processes for a broad range of applications, including infectious disease diagnostics, oncology, and pharmacogenomics.10. The company generates revenue primarily through its software solutions, which are typically offered on a subscription basis.Following a majority stake acquisition by Summa Equity in September 2022, UgenTec NV aims to capitalize on its established growth and innovation in molecular diagnostics. UgenTec plans to penetrate additional markets in North America and Asia by 2024, leveraging this investment to meet the increasing demand for efficient laboratory solutions.
Who invested in UgenTec NV
4 investors across 2 rounds
See all investors in UgenTec NV
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about UgenTec NV
Who invested in UgenTec NV?
UgenTec NV has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has UgenTec NV raised?
UgenTec NV has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did UgenTec NV last raise money?
UgenTec NV's most recent round on record is a Series A, in Apr 2018.
What does UgenTec NV do?
Founded in 2014 in Hasselt, Belgium, UgenTec NV specializes in developing advanced software for molecular diagnostics.
Where is UgenTec NV headquartered?
UgenTec NV is headquartered in Hasselt, Belgium.
Which VCs invest in companies like UgenTec NV?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back healthcare it companies at UgenTec NV's stage. Their profiles are linked below.
VCs backing healthcare it startups at Series A
Raising like UgenTec NV? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.